Keyphrases
Pediatric
100%
Nonunion
100%
Ketorolac
100%
Long Bone Fracture
100%
Matched Cohort Analysis
100%
Hazard Ratio
45%
Confidence Interval
27%
Lower Extremity Fracture
18%
Femoral Fractures
18%
High Risk
9%
Inclusion Criteria
9%
Retrospective Cohort Study
9%
United States
9%
Lower Extremity
9%
Canada
9%
Fracture Healing
9%
Fold Increase
9%
Serious Complications
9%
Risk Ratio
9%
Upper Extremity
9%
Morbidity Burden
9%
Analgesia
9%
Pediatric Population
9%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
9%
Absolute Risk
9%
Subgroup Analysis
9%
Healthcare Organizations
9%
Patient Morbidity
9%
Opiates
9%
Tibial
9%
Fibula Fracture
9%
Fracture Risk
9%
18 Years Old
9%
Upper Extremity Injury
9%
Postoperative Pain Management
9%
Pediatric Fracture
9%
Propensity Score Matching
9%
Economic Burden
9%
Fracture Location
9%
Fracture Nonunion
9%
Western Europe
9%
Humeral Fractures
9%
Pain Recovery
9%
Ulna Fractures
9%
TriNetX
9%
Medical Codes
9%
Medicine and Dentistry
Pediatrics
100%
Cohort Analysis
100%
Nonunion
100%
Ketorolac
100%
Hazard Ratio
41%
Limb Fracture
25%
Analgesia
16%
Femur Fracture
16%
Health Care
8%
Postoperative Pain
8%
Clinician
8%
Retrospective Cohort Study
8%
Fracture Healing
8%
Opiate
8%
Upper Limb
8%
Nonsteroid Antiinflammatory Agent
8%
Subgroup Analysis
8%
Propensity Score Matching
8%
Humerus Fracture
8%
Ulna Fracture
8%
Pharmacology, Toxicology and Pharmaceutical Science
Fracture Nonunion
100%
Ketorolac
100%
Limb Fracture
25%
Femur Fracture
16%
Cohort Study
8%
Opiate
8%
Non-Steroidal Anti-Inflammatory Drug
8%
Fracture Healing
8%
Postoperative Pain
8%
Ulna Fracture
8%
Humerus Fracture
8%